Science Translational Medicine (@ScienceTM) header
Science Translational Medicine (@ScienceTM) profile picture

Science Translational Medicine is the leading weekly online journal publishing translational research at the intersection of science, engineering and medicine.

Washington, DC
Joined February 2011
Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)Photo by Science Translational Medicine (@ScienceTM)
A noninvasive brain stimulation technique can relieve symptoms of subclinical depression in adults, scientists present liver-targeted therapies that can rescue inherited metabolic disorders in mice, and more this week in #ScienceTranslationalMedicine. scim.ag/4zUwAIz
7
2
53
6,323
A new clinical trial tests a combo of #osimertinib, platinum and etoposide chemotherapy in patients with EGFR-mutant #LungCancer, and reveals how lineage plasticity shapes the risk of #SCLC transformation and drug resistance. @jmchan88 @MSKCancerCenter scim.ag/4ewEoYg
2
598
Science Translational Medicine retweeted
Excited that our @ScienceTM manuscript was published this week. Great work Andrew Haddad (1st author) in my lab and the entire @AllofUsResearch team. In ~100k participants with linked WGS and EHR data, EVERY participant carried a #PGx variant in just 16 genes and nearly all had potentially actionable findings where there is a @cpicpgx guideline or FDA labeling recommending a change in prescribing. ~24% had already been exposed to impacted drug. We also reported allele, diplotype, and predicted phenotype frequencies and identified >17k novel variants. Article➡️ science.org/doi/10.1126/scit… More info➡️bit.ly/4fsla6m @pittpharmacy @iPrecisionMed @PittHealthSci @UPMCnews
2
4
650
Science Translational Medicine retweeted
¡Buenos días! No todos los sábados te despiertas viendo tu nombre junto al de grandes colegas y científicos en @ScienceTM de @ScienceMagazine . Gracias a otra fructífera colaboración liderada por @BernasconiFosco , de @OlafBlankeLab , seguimos aportando desde @UtmSantPau nuevos conocimientos sobre las alucinaciones visuales en la enfermedad de Parkinson. science.org/doi/10.1126/scit…
1
4
27
2,507
Sleep-like slow brain waves are more frequent in patients with #ParkinsonsDisease and correlate with a greater hallucination burden and poorer cognitive function, according to a new EEG analysis of patients. @OlafBlankeLab @BernasconiFosco @Neuro_X_EPFL scim.ag/489CGIP
4
673
By analyzing a massive collection of #TcellReceptor chains from 150,000+ patient samples, researchers develop a pipeline to accelerate the discovery and validation of public T cell receptors for immunotherapeutic design. @BioNTech_Group scim.ag/48BezCN
4
7
1,029
A new drug screening study identifies the approved blood thinner #dabigatran as a potent #osteoarthritis treatment in large animals, showing that it can inhibit both TNF-alpha and IL-1-beta through the protein BIG2 and dampen inflammation. @OrthoAtYale scim.ag/3WF6bj4
485
A #pharmacogenomics analysis of 100,000 participants in the @AllofUsResearch program sheds light on the landscape of pharmacogene variants in diverse ancestries and tackles gaps in genomics knowledge in underrepresented groups. @philempey @pittpharmacy scim.ag/4t0sL1S
2
1
4
628
A study of 100,000 diverse Americans tackles gaps in pharmacogenomics representation, scientists connect sleep-like slow brain waves to hallucinations and poorer cognition in Parkinson’s disease, and more this week in #ScienceTranslationalMedicine. scim.ag/48Lwery
3
13
8,030
By comparing PET scans between patients with early-onset and late-onset #AlzheimersDisease, researchers uncover key differences in tauopathy between the age groups that could inform future diagnostics and therapeutics. @UCSFmac scim.ag/4z9byVl
1
5
12
1,260
How well does #VRC01 protect against #HIV? An analysis of the post-infusion period in two clinical trials shows that prophylaxis blocks infections with sensitive strains but that breakthrough infections still occur after infusions stopped. @fredhutch scim.ag/4elPMWL
3
5
1,221
A triplet combination therapy based on first-line #regorafenib remodels the tumor microenvironment in patients with advanced #GastricCancer while displaying promising safety and response rate, according to a new phase 2 clinical trial. @NccriOfficial scim.ag/4Agt1vJ
3
13
1,514
In a unique human challenge study, researchers interrogate how preexisting immunity and antibodies against the four serotypes of #dengue influence viremia, T cell responses, and immune activation in a safe and controlled setting. @CamilaOdio @NIH scim.ag/3W4jxVS
1
2
6
1,332
By analyzing a massive collection of #TcellReceptor chains from 150,000+ patient samples, researchers develop a pipeline to accelerate the discovery and validation of public T cell receptors for immunotherapeutic design. @BioNTech_Group scim.ag/48BezCN
2
4
13
1,359
Clinical trials of an anti-HIV antibody offer clues to prevent viral escape and resistance, a massive dataset accelerates the discovery of T cell receptors for future cancer therapeutics, and more this week in #ScienceTranslationalMedicine. scim.ag/4sGXxwj
2
5
18
8,310
A new analysis of mice and samples from patients with #psoriasis identifies CHI3L2 as a central driver of the condition, showing that it propels an inflammatory loop by reprogramming phospholipid metabolism in keratinocytes. @XJTU_China scim.ag/4yYjMzC
1
1
7
1,068
New work links synovial inflammation in #osteoarthritis to a signaling axis involving CD74 and ENO2 that reprograms macrophages into an inflammatory and metabolically active state—but shows these cells can be targeted to treat the disease in mice. scim.ag/4A4r7yx
2
2
4
1,042
By applying a unique polyene scaffold, researchers engineer a next-generation, broad-spectrum #antifungal that selectively targets ergosterol without binding to cholesterol, avoiding severe toxicity linked to drugs like amphotericin B. scim.ag/4yyYZSP
2
3
1,248
A new bispecific antibody targets both #CCR8 to deplete regulatory T cells and CD3 to revitalize the broader anti-tumor T cell armada. It combated multiple tumor types and potentiated immunotherapy in mice while being safe in large animals. @genentech scim.ag/4e4t05H
3
19
1
105
6,218
In a unique human challenge study, researchers interrogate how preexisting immunity and antibodies against the four serotypes of #dengue influence viremia, T cell responses, and immune activation in a safe and controlled setting. @CamilaOdio @NIH scim.ag/3W4jxVS
4
7
1,134